Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Herr

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinomaPadmanee Sharma, Yu Shen, Sijin Wen, et al.
European Urology|August 11, 2007
Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomyJoseph A Pettus, Hikmat Al-Ahmadie, Daniel A Barocas, et al.
European Urology|August 11, 2012
Epidemiology and risk factors of urothelial bladder cancerMaximilian Burger, James W F Catto, Guido Dalbagni, et al.
The Journal of Urology|September 8, 2020
Electronic Rapid Fitness Assessment Identifies Factors Associated with Adverse Early Postoperative Outcomes following Radical CystectomyGregory T Chesnut, Amy L Tin, Daniel D Sjoberg, et al.
BJU International|June 20, 2025
Prospective health-related quality of life in women undergoing radical cystectomy and urinary diversionMatthew B Clements, Kelly R Pekala, Amy L Tin, et al.
Cancer|January 7, 2014
Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710John P Christodouleas, Brian C Baumann, Jiwei He, et al.
Urologic Oncology|January 26, 2023
Bladder preservation after neoadjuvant therapy - 2021 IBCN updates part 1Patrick J Hensley, Roland Seiler, Harry Herr, et al.
Cancer Immunity|December 19, 2003
Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancerPadmanee Sharma, Sacha Gnjatic, Achim A Jungbluth, et al.
European Urology Oncology|September 1, 2024
Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG)Roberto Contieri, Mark S Soloway, Paolo Gontero, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 19, 2022
Feasibility of a geriatric comanagement (GERICO) pilot program for patients 75 and older undergoing radical cystectomyAllison S Letica-Kriegel, Amy L Tin, Garrett M Nash, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinomaPadmanee Sharma, Yu Shen, Sijin Wen, et al.
European Urology|August 11, 2007
Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomyJoseph A Pettus, Hikmat Al-Ahmadie, Daniel A Barocas, et al.
European Urology|August 11, 2012
Epidemiology and risk factors of urothelial bladder cancerMaximilian Burger, James W F Catto, Guido Dalbagni, et al.
The Journal of Urology|September 8, 2020
Electronic Rapid Fitness Assessment Identifies Factors Associated with Adverse Early Postoperative Outcomes following Radical CystectomyGregory T Chesnut, Amy L Tin, Daniel D Sjoberg, et al.
BJU International|June 20, 2025
Prospective health-related quality of life in women undergoing radical cystectomy and urinary diversionMatthew B Clements, Kelly R Pekala, Amy L Tin, et al.
Cancer|January 7, 2014
Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710John P Christodouleas, Brian C Baumann, Jiwei He, et al.
Urologic Oncology|January 26, 2023
Bladder preservation after neoadjuvant therapy - 2021 IBCN updates part 1Patrick J Hensley, Roland Seiler, Harry Herr, et al.
Cancer Immunity|December 19, 2003
Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancerPadmanee Sharma, Sacha Gnjatic, Achim A Jungbluth, et al.
European Urology Oncology|September 1, 2024
Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG)Roberto Contieri, Mark S Soloway, Paolo Gontero, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 19, 2022
Feasibility of a geriatric comanagement (GERICO) pilot program for patients 75 and older undergoing radical cystectomyAllison S Letica-Kriegel, Amy L Tin, Garrett M Nash, et al.
Pageof 7